Cardiff Oncology, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Cardiff Oncology, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2011 to Q3 2024.
  • Cardiff Oncology, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$11.9M, a 21.8% decline year-over-year.
  • Cardiff Oncology, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$43M, a 5.34% decline year-over-year.
  • Cardiff Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$41.4M, a 7.07% decline from 2022.
  • Cardiff Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38.7M, a 36.8% decline from 2021.
  • Cardiff Oncology, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28.3M, a 46.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$43M -$11.9M -$2.12M -21.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$40.9M -$11.8M -$628K -5.63% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$40.2M -$10M +$1.21M +10.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$41.4M -$9.34M -$640K -7.36% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$40.8M -$9.73M -$1.16M -13.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$39.6M -$11.2M -$707K -6.77% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$38.9M -$11.2M -$230K -2.09% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$38.7M -$8.7M +$745K +7.89% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$39.4M -$8.57M -$1.66M -24% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$37.8M -$10.4M -$3.69M -54.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$34.1M -$11M -$5.81M -112% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$28.3M -$9.44M -$2.85M -43.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$25.4M -$6.91M -$2.42M -53.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$23M -$6.76M -$2.63M -63.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$20.4M -$5.18M -$1.09M -26.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$19.3M -$6.6M -$2.35M -55.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$17M -$4.5M -$355K -8.58% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$16.6M -$4.12M +$1.3K +0.03% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$16.6M -$4.09M -$184K -4.72% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$16.4M -$4.24M -$84.1K -2.02% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$16.3M -$4.14M -$372K -9.87% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$16M -$4.13M -$378K -10.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$15.6M -$3.9M +$881K +18.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$16.5M -$4.16M -$1.59M -61.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$14.9M -$3.77M +$522K +12.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$15.4M -$3.75M +$4.3M +53.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$19.7M -$4.79M +$5.21M +52.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$24.9M -$2.57M +$5.98M +69.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$30.9M -$4.29M +$5.9M +57.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$36.8M -$8.05M +$2.16M +21.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$38.9M -$10M +$263K +2.56% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 -$39.2M -$8.55M -$1.17M -15.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-02-26
Q3 2016 -$38M -$10.2M -$7.46M -273% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$30.6M -$10.2M -$22.2K -0.22% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$30.6M -$10.3M -$3.09M -43% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$27.5M -$7.38M -$2.7M -57.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-15
Q3 2015 -$24.8M -$2.74M +$2.64M +49.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.4M -$10.2M -$9.1M -845% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$18.3M -$7.17M -$3.98M -125% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$14.3M -$4.68M -$3.65M -355% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$10.7M -$5.38M -$974K -22.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$9.7M -$1.08M +$4.19M +79.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$13.9M -$3.19M -$2.08M -187% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 -$11.8M -$1.03M +$5.3M +83.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-10
Q3 2013 -$17.1M -$4.4M -$3.75M -577% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$13.4M -$5.27M -$1.84M -53.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$11.5M -$1.11M +$51.9K +4.47% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q4 2012 -$11.6M -$6.33M -$5.08M -407% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$6.49M -$650K -$659K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$5.83M -$3.43M -$2.98M -663% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$2.85M -$1.16M -$611K -111% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 -$2.24M -$1.25M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 $9.27K* Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$449K Apr 1, 2011 Jun 30, 2011 10-K 2013-04-01
Q1 2011 -$552K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.